122 related articles for article (PubMed ID: 8879847)
1. alpha-Glutathione S-transferase levels in chronic hepatitis C infection and the effect of alpha-interferon therapy.
Thorburn D; Bird GL; Spence E; MacSween RN; Mills PR
Clin Chim Acta; 1996 Sep; 253(1-2):171-80. PubMed ID: 8879847
[TBL] [Abstract][Full Text] [Related]
2. The role of alpha-glutathione S-transferase in the monitoring of hemodialysis patients with hepatitis C virus infection undergoing high-dose interferon-alpha-2b therapy.
Boran M; Cetin S
Nephron; 1999; 82(1):22-6. PubMed ID: 10224480
[TBL] [Abstract][Full Text] [Related]
3. Blood serum glutathione alpha s-transferase (alpha GST) activity during antiviral therapy in patients with chronic hepatitis C.
Mazur W; Gonciarz M; Kajdy M; Mazurek U; Jurzak M; Wilczok T; Gonciarz Z
Med Sci Monit; 2003 Aug; 9 Suppl 3():44-8. PubMed ID: 15156612
[TBL] [Abstract][Full Text] [Related]
4. Comparison between serum alpha-glutathione S-transferase and aminotransaminases in detecting cytolysis in hepatitis C-infected children.
Namour F; Morali A; Ilardo C; Abballe X; Maury F; Guéant JL
J Pediatr Gastroenterol Nutr; 1999 May; 28(5):534-7. PubMed ID: 10328133
[TBL] [Abstract][Full Text] [Related]
5. alpha-Glutathione S-transferase as a marker of hepatocellular damage in chronic hepatitis C virus infection.
Nelson DR; Lim HL; Oliver D; Qian KP; Davis GL; Lau JY
Am J Clin Pathol; 1995 Aug; 104(2):193-8. PubMed ID: 7639195
[TBL] [Abstract][Full Text] [Related]
6. Long-term histologic improvement and loss of detectable intrahepatic HCV RNA in patients with chronic hepatitis C and sustained response to interferon-alpha therapy.
Marcellin P; Boyer N; Gervais A; Martinot M; Pouteau M; Castelnau C; Kilani A; Areias J; Auperin A; Benhamou JP; Degott C; Erlinger S
Ann Intern Med; 1997 Nov; 127(10):875-81. PubMed ID: 9382365
[TBL] [Abstract][Full Text] [Related]
7. Association of response to combined interferon alpha-2b and ribavirin therapy in patients of chronic hepatitis c with serum alanine aminotransferase levels and severity of the disease on liver biopsy.
Nadeem A; Hussain MM; Aslam M; Hussain T; Butt IF; Ali Khan S; Asad A
J Ayub Med Coll Abbottabad; 2009; 21(2):103-6. PubMed ID: 20524482
[TBL] [Abstract][Full Text] [Related]
8. Genotype, serum level of HCV-RNA and response to interferon-alpha treatment in patients with chronic hepatitis C.
Clarysse C; Van den Eynde C; Nevens F; Portier C; Aelbrecht N; Fevery J; Yap SH
Neth J Med; 1995 Dec; 47(6):265-71. PubMed ID: 8569931
[TBL] [Abstract][Full Text] [Related]
9. Studies of the effectiveness of interferon alpha treatment for chronic hepatitis C in children.
Czerwionka-Szaflarska M; Chrobot A; Szaflarska-Szczepanik A
Med Sci Monit; 2000; 6(5):964-70. PubMed ID: 11208439
[TBL] [Abstract][Full Text] [Related]
10. Interferon alpha therapy in patients with chronic type C hepatitis: changes of serum ALT, anti-HCV & HCV-RNA.
Cho HJ; Dong SH; Lee MS; Kim HY; Park CK; Yoo JY; Polito A; Quan S; Han JH
Korean J Intern Med; 1992 Jan; 7(1):13-7. PubMed ID: 1282364
[TBL] [Abstract][Full Text] [Related]
11. [Studies on the relationship between purified alpha class glutathione S-transferase (GST-alpha) and hepatocellular damage].
Ren H; Li C; Tan Z; Wang Y; Chen X; Zhou H
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1997 Sep; 11(3):232-6. PubMed ID: 15617336
[TBL] [Abstract][Full Text] [Related]
12. Preferential virological response to interferon-alpha 2a in patients with chronic hepatitis C infected by virus genotype 3a and exhibiting a low gamma-GT/ALT ratio.
Mihm S; Hartmann H; Fayyazi A; Ramadori G
Dig Dis Sci; 1996 Jun; 41(6):1256-64. PubMed ID: 8654161
[TBL] [Abstract][Full Text] [Related]
13. Plasma alpha-glutathione S-transferase assessed as a marker of liver damage in patients with chronic hepatitis C.
Vaubourdolle M; Chazouillères O; Briaud I; Legendre C; Serfaty L; Poupon R; Giboudeau J
Clin Chem; 1995 Dec; 41(12 Pt 1):1716-9. PubMed ID: 7497611
[TBL] [Abstract][Full Text] [Related]
14. Parameters predicting response to alpha-interferon treatment in chronic hepatitis C.
Glück T; Seelig R; Dette S; Bühring HJ; Renz M; Kwon S; Wiedmann KH; Weber P
Hepatogastroenterology; 1997; 44(14):484-91. PubMed ID: 9164523
[TBL] [Abstract][Full Text] [Related]
15. Determination of plasma alpha-glutathione S-transferases in patients with HCV-related chronic infection: its significance and possible clinical relevance.
Loguercio C; Tuccillo C; Caporaso N; Del Vecchio Blanco G; Morisco F; Guerriero C; di Santolo SS; Valenza LM; Del Vecchio Blanco C
Liver; 1998 Jun; 18(3):166-72. PubMed ID: 9716226
[TBL] [Abstract][Full Text] [Related]
16. Persistent hepatitis C viremia predicts late relapse after sustained response to interferon-alpha in chronic hepatitis C. TriVeneto Viral Hepatitis Group.
Chemello L; Cavalletto L; Casarin C; Bonetti P; Bernardinello E; Pontisso P; Donada C; Belussi F; Martinelli S; Alberti A
Ann Intern Med; 1996 Jun; 124(12):1058-60. PubMed ID: 8633819
[TBL] [Abstract][Full Text] [Related]
17. Therapy of hepatitis C: patients with normal aminotransferase levels.
Marcellin P; Lévy S; Erlinger S
Hepatology; 1997 Sep; 26(3 Suppl 1):133S-136S. PubMed ID: 9305678
[TBL] [Abstract][Full Text] [Related]
18. Clinical presentation, outcome, and response to therapy among patients with acute exacerbation of chronic hepatitis C.
Sagnelli E; Pisaturo M; Stanzione M; Messina V; Alessio L; Sagnelli C; Starace M; Pasquale G; Coppola N
Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1174-1180.e11. PubMed ID: 23591280
[TBL] [Abstract][Full Text] [Related]
19. Serum HCV RNA levels in patients with chronic hepatitis C given a second course of interferon alpha-2b treatment after relapse following initial treatment.
Weiland O; Zhang YY; Widell A
Scand J Infect Dis; 1993; 25(1):25-30. PubMed ID: 8384732
[TBL] [Abstract][Full Text] [Related]
20. Better efficacy of a 12-month interferon alfa-2b retreatment in patients with chronic hepatitis C relapsing after a 6-month treatment: a multicenter, controlled, randomized trial. Le Groupe D'étude et De Traitement du Virus De L'hépatite C (Get.Vhc).
Payen JL; Izopet J; Galindo-Migeot V; Lauwers-Cances V; Zarski JP; Seigneurin JM; Dussaix E; Voigt JJ; Selves J; Barange K; Puel J; Pascal JP
Hepatology; 1998 Dec; 28(6):1680-6. PubMed ID: 9828235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
